ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2020 American Transplant Congress

    Efficacy of Radiofrequency Ablation in the Treatment of Patients with Hepatocellular Carcinoma and Compensated Liver Disease: A Pathological Evaluation of Liver Explants

    W. Alhamoudi1, I. Salih2, S. Yousif2, M. Shawkat3, K. Bzeizi2, A. Albenmousa2, S. Alghamdi2, M. Sturdevant2, D. Broering2, H. Alsuhaibani2

    1Medicine, King Saud University, Riyadh, Saudi Arabia, 2Liver Transplant, King Faisal Specialist Hospital, Riyadh, Saudi Arabia, 3Internal Medicine, Minia University, Minia, Egypt

    *Purpose: Radiofrequency ablation (RFA) is a safe and effective treatment for patients with limited hepatocellular carcinoma (HCC). Ablative outcomes have been largely based on radiological…
  • 2020 American Transplant Congress

    Effectiveness of Preemptive Therapy in the Prevention of Cytomegalovirus (CMV) Disease in High-Risk (Donor Seropositive/Recipient Seronegative) Liver Transplant Recipients

    J. A. Morillas, K. Brizendine

    Infectious Disease, Cleveland Clinic Foundation, Cleveland, OH

    *Purpose: Guidelines recommend preemptive therapy (PET) as one strategy for prevention of CMV disease in high risk liver transplant recipients (LTR). However, questions have been…
  • 2020 American Transplant Congress

    Increasing Utilization of Anonymous Nondirected Living Liver Donors in the United States

    M. H. Raza1, M. Lo2, Y. Genyk3, L. Sher3, J. Emamaullee3

    1Keck School of Medicine of USC, Los Angeles, CA, 2University of Southern California, Los Angeles, CA, 3Surgery, University of Southern California, Los Angeles, CA

    *Purpose: Recently, there has been growth in the rate of living donor liver transplantation in the U.S. Increasingly, liver transplant programs are evaluating potential anonymous…
  • 2020 American Transplant Congress

    The Association of Body Weight Gain/Change and Hepatocellular Carcinoma Recurrence after Liver Transplant

    O. Ahmed1, M. Sauer1, N. Vachharajani1, S. H. Chang2, Y. Park2, A. S. Khan1, W. C. Chapman1, M. B. Doyle1

    1Department of Surgery, Washington University School of Medicine, St Louis, MO, 2Division of Public Health Sciences, Washington University School of Medicine, St Louis, MO

    *Purpose: Functional recovery in liver transplant recipients is commonly confounded by weight changes relating to various aspects of liver disease such as cachexia, ascites and…
  • 2020 American Transplant Congress

    Live Donor Liver Transplant Offers Higher Survival, Improved Quality of Liver and Lower Morbidity for Recipients with Low MELD Score

    M. Black, J. Bayer, H. Fernandez, E. Martinez, G. McKenna, N. Onaca, R. Ruiz, G. Testa, A. Wall, T. Ma, G. Saracino, S. Asrani, A. Gupta

    Baylor University Medical Center, Dallas, TX

    *Purpose: The shortage of cadaveric liver grafts contributes to significant waitlist mortality. Patients with low MELD-Na score (
  • 2020 American Transplant Congress

    Alcohol Relapse after Liver Transplant for Alcohol-Related Cirrhosis: A Longitudinal Assessment of Risk Factors for Relapse and Long-Term Survival

    B. Rice, N. Mehta, J. L. Dodge, J. D. Grab, C. Sherman

    University of California San Francisco, San Francisco, CA

    *Purpose: Relapse to alcohol after liver transplant (LT) is common but likely underreported in patients with alcohol-related cirrhosis (AC). The aim of this study was…
  • 2020 American Transplant Congress

    Serum Cystatin C Predicts Kidney-Related Outcomes and Transplant-Free Survival in Patients with End-Stage Liver Disease and Low Body Mass Index

    N. Shankar1, M. Garcia Saenz de Sicilia2, A. Duarte-Rojo3, S. K. Asrani4, J. F. Trotter4, G. B. Klintmalm4, B. V. Fischbach5, S. A. Gonzalez5

    1Internal Medicine, Baylor Scott & White University Medical Center, Dallas, TX, 2University of Arkansas for Medical Sciences, Little Rock, AR, 3Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Center for Liver Diseases, Pittsburgh Liver Research Center, University of Pittsburgh Medical Center, Pittsburgh, PA, 4Baylor Simmons Transplant Institute, Dallas, TX, 5Baylor Simmons Transplant Institute, Fort Worth, TX

    *Purpose: Liver transplant (LT) candidates with sarcopenia are disadvantaged by creatinine-based assessment of renal function as creatinine overestimates glomerular filtration rate (GFR). Low body mass…
  • 2020 American Transplant Congress

    Atrial Fibrillation Predicts Inferior Survival in Liver Transplant Recipients of Advanced Age in a Large Multicenter U.S. Cohort

    M. German1, A. Hristov1, A. Lee1, F. Osman1, A. Kwong2, D. Devuni3, C. Wang4, J. Boike5, J. Jo5, L. VanWagner5, M. Serper6, R. Sharma7, E. Verna7, J. Shor3, A. Koteish8, G. Sehmbey9, A. Seetharam9, N. John2, Y. Patel10, M. Kappus10, T. Couri11, S. Paul11, R. Salgia12, Q. Nhu13, C. Frenette13, J. Lai4, A. Goel2, E. Spengler1

    1U of Wisconsin, Madison, WI, 2Stanford, Palo Alto, CA, 3U of Massachusetts, Worcester, MA, 4U of California, San Francisco, CA, 5Northwestern, Chicago, IL, 6U of Pennsylvania, Philadelphia, PA, 7Columbia, New York, NY, 8Florida Hospital, Orlando, FL, 9U of Arizona, Phoenix, AZ, 10Duke, Durham, NC, 11U of Chicago, Chicago, IL, 12Henry Ford Hospital, Detroit, MI, 13Scripps, San Diego, CA

    *Purpose: More liver transplants (LT) are being performed in patients >65 years (y) - a population with higher rates of cardiovascular (CV) disease. It is…
  • 2020 American Transplant Congress

    Impact and Outcomes of Primary Cytomegalovirus Infection in Seronegative Abdominal Solid Organ Transplant Recipients of Cytomegalovirus Unexposed Donors (D-/R-)

    M. Jorgenson1, M. Hillis1, N. Friedlander1, A. Gracon2, D. Yang2, G. Leverson2, J. Smith2, R. Redfield2

    1UWHC, Madison, WI, 2UWMF, Madison, WI

    *Purpose: Primary cytomegalovirus infection (CMV) in high risk (D+/R-) abdominal solid organ transplant recipients (aSOTRs) is well described, however there is a paucity of literature…
  • 2020 American Transplant Congress

    Liver Transplantation from Donors after Circulatory Death Using “tPA”Protocol: The University of Miami Experience

    R. Vianna, A. Farag, G. Selvaggi, A. Tekin, W. De Faria, M. Morsi, R. Miyashiro, T. Beduschi

    University of Miami, Miami Transplant Institute, Miami, FL

    *Purpose: Expansion of liver transplantation (LT) from donors after circulatory death (DCD) has been increasingly used to overcome the persistent organ shortage and long waiting…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences